Related Experiment Video
Updated: Apr 21, 2026

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
Published on: March 24, 2023
Allergic contact dermatitis to 2-octyl cyanoacrylate
Casey Bowen1, Jeff Bidinger, Chad Hivnor
1Department of Dermatology, San Antonio Military Medical Center South, 2200 Bergquist Dr, Ste 1, Lackland AFB, TX 78236, USA. caseybowen.2@us.af.mil.
Four patients experienced allergic contact dermatitis (ACD) after using 2-octyl cyanoacrylate skin adhesive. This highlights a potential underrecognized allergy to this common surgical closure method.
Area of Science:
- Dermatology
- Allergology
- Wound Healing
Background:
- Cyanoacrylates are frequently utilized as topical skin adhesives in diverse medical settings, including emergency departments, clinics, and operating rooms.
- Their widespread application is due to their efficacy in wound closure.
- Postsurgical wound management often involves the use of these adhesives.
Observation:
- Four patients presented with allergic contact dermatitis (ACD) subsequent to surgical site closure using 2-octyl cyanoacrylate.
- The development of ACD indicates a hypersensitivity reaction to the adhesive.
- This observation suggests a potential adverse effect associated with 2-octyl cyanoacrylate.
Findings:
- Diagnostic challenge testing confirmed sensitivity to 2-octyl cyanoacrylate in the affected patients.
- The study identified 2-octyl cyanoacrylate as a potential allergen.
- This confirms a causal link between the adhesive and the allergic reactions observed.
Implications:
- The findings suggest that cyanoacrylate allergy may be underrecognized in clinical practice.
- Increased awareness and diagnostic vigilance for cyanoacrylate allergy are warranted.
- Further research into the prevalence and mechanisms of cyanoacrylate allergy is recommended.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Allergic Drug Reactions
Allergic Reactions: Anaphylaxis
Allergic Reactions
Anionic Chain-Growth Polymerization: Overview
Hypersensitivity Reactions: Immune-Complex Reactions

